azd2936
Showing 1 - 4 of 4
Non-Small-Cell Lung Carcinoma Trial in Worldwide (AZD2936)
Recruiting
- Non-Small-Cell Lung Carcinoma
- AZD2936
-
Orange, California
- +29 more
Aug 18, 2022
Gastric Cancer Trial in Worldwide (AZD2936, MEDI5752, FOLFOX)
Recruiting
- Gastric Cancer
- AZD2936
- +3 more
-
Beijing, China
- +25 more
Jan 18, 2023
Advanced or Metastatic NSCLC Trial in Worldwide (Datopotamab deruxtecan, Durvalumab, Carboplatin)
Recruiting
- Advanced or Metastatic NSCLC
- Datopotamab deruxtecan
- +4 more
-
Santa Ana, California
- +15 more
Dec 13, 2022
Metastatic NSCLC (NSCLC) Trial in Worldwide (Durvalumab, Danvatirsen, Oleclumab)
Active, not recruiting
- Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Durvalumab
- +9 more
-
Iowa City, Iowa
- +45 more
Jan 13, 2023